15 July 2020>: Clinical Research
Argatroban Increased the Basal Vein Drainage and Improved Outcomes in Acute Paraventricular Ischemic Stroke Patients
Shoufeng Liu 12AE* , Peipei Liu 2BCDEF* , Po Wang 3BC , Fang Zhang 4BD , Lijun Wang 5BD , Yu Wang 6BD , Hao Lu 7B , Xiaofeng Ma 4AG*DOI: 10.12659/MSM.924593
Med Sci Monit 2020; 26:e924593
Table 2 Complications and adverse events.
Complication or event | Control n=30 | Argatroban n=30 | P value |
---|---|---|---|
Complications | |||
Deaths | 0 (0) | 0 (0) | 1.00 |
Myocardial infarctions | 0 (0) | 0 (0) | 1.00 |
Recurrent strokes | 1 (3) | 0 (0) | 0.31 |
Cerebral hemorrhage | 0 (0) | 0 (0) | 1.00 |
Hemorrhage of digestive tract | 0 (0) | 1 (3) | 0.31 |
Fever (>38°C) | 1 (3) | 1 (3) | 1.00 |
Event | |||
All events | |||
At least one adverse event | 1 (3) | 1 (3) | 1.00 |
Any adverse event leading to discontinuation | 0 (0) | 0 (0) | 1.00 |
Any serious adverse event | 0 (0) | 0 (0) | 1.00 |
Infection after stroke | 1 (3) | 1 (3) | 1.00 |
Suspected lung infection | 1 (3) | 0 (0) | 0.31 |
Urinary tract infection | 0 (0) | 0 (0) | 1.00 |
Upper respiratory tract infection | 0 (0) | 1 (3) | 0.31 |
Digestive system infection | 0 (0) | 0 (0) | 1.00 |
Herpes virus infection | 0 (0) | 0 (0) | 1.00 |
Antibiotic therapy | 1 (3) | 0 (0) | 0.31 |
Data are n (%). |